NTRC Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include Candel Therapeutics and Captor Therapeutics.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. |  Captor Therapeutics Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases. | ||
Founding Date | Founding Date 1990 | Founding Date 1999 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Needham, US HQ | Locations Wrocław, PL HQ Allschwil, CH |
Employees | Employees 61821% increase | Employees 50 | Employees 88 |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 176.8 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($164.1m) (FY, 2025) | Net income ($38.2m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 64.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Candel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View companyCaptor Therapeutics
HQ
Wrocław, PL
Employees
88
Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases.
View company